AstraZeneca CEO Pascal Soriot proposes a novel fix to the drug pricing law’s alleged cancer problem

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution...